IL-17 retains pro-fibrotic state of various cells, impacts differentiation of fibroblasts, inhibits autophagy and exacerbates overall inflammatory status, implicating its role in the pathogenesis of SSc [54, 64, 114, 121]. This evidence concerns the gene IL17A and systemic sclerosis.